As Chief Compliance Officer and Vice President for Novo Nordisk Inc., Jill Fallows Macaluso Esq., RN, is charged with developing, operating, and overseeing an effective healthcare compliance program within the United States.
Utilizing 15 years of industry experience, Ms. Fallows Macaluso has been instrumental in driving the evolution of Novo Nordisk’s compliance program to support industry leading business practices.
By serving as a corporate compliance partner, she has spearheaded efforts focused on rebranding and operational efficiency, as well as, strengthening global partnerships. As an Executive Team member, she chairs the Executive Compliance Committee and plays an active role ensuring compliance is incorporated into company decision-making processes.
Ms. Fallows Macaluso began assuming leadership responsibilities when she joined the Compliance Department as Senior Director in 2012. Prior to joining the Compliance Department, she was Senior Corporate Counsel in the Novo Nordisk Inc. Legal Department for nine years where she held several key positions.
Previously, Ms. Fallows Macaluso was with the General Corporate and Healthcare practice of Day Pitney, LLP. She holds a Bachelor of Science in Nursing from the University of Pennsylvania and a Juris Doctorate from Rutgers University School of Law.